Attitudes towards influenza and uptake of the flu vaccine: A survey of pharmacy staff working in English hospitals

Hamilton, Ryan A; Krockow, Eva M.; Vekria, Priya

doi:10.1016/j.vaccine.2021.03.091

Cited by 4 publications

(3 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other factors deemed relevant included knowledge about vaccine effectiveness, vaccine safety, and transmissibility of COVID-19 post-vaccination (3 items) [29]; trust in Government (1 item; adapted from [30]); and fear of needles (1 item; [13]). Items were based on items used in similar studies that have examined the psychological determinants of vaccine intention [13,19,31,32] and are presented in Appendix A. All items (except 'fear of needles') were measured on a 5-point Likert scale, with higher scores representing higher levels of agreement / more anticipated regret.…”

Section: Beliefs and Attitudes About Covid-19 And Covid-19 Booster Va...mentioning

confidence: 99%

Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England

Meyer¹,

Goffe²,

Antonopoulou³

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: COVID-19 continues to pose a threat to public health. Booster vaccine programmes are critical to achieve population-level immunity. Stage theory models of health behaviour can help our understanding of vaccine decision-making in the context of perceived threats of COVID-19.Purpose: To use the Precaution Adoption Process Model (PAPM) to understand decision-making about the COVID-19 booster vaccine (CBV) in England.Methods: An online, cross-sectional survey informed by the PAPM, the extended Theory of Planned Behaviour and Health Belief Model administered to people over the age of 50 residing in England, UK in October 2021. A multivariate, multinomial logistic regression model was used to examine associations with the different stages of CBV decision-making.Results: Of the total 2,004 participants: 135 (6.7%) were unengaged with the CBV programme; 262 (13.1%) were undecided as to whether to have a CBV; 31 (1.5%) had decided not to have a CBV; 1,415 (70.6%) had decided to have a CBV; and 161 (8.0%) had already had their CBV. Being unengaged was positively associated with beliefs in their immune system to protect against COVID-19, being employed, and low household income; and negatively associated with CBV knowledge, a positive COVID-19 vaccine experience, subjective norms, anticipated regret of not having a CBV, and higher academic qualifications. Being undecided was positively associated with beliefs in their immune system and having previously received the Oxford/AstraZeneca (as opposed to Pfizer/BioNTech) vaccine; and negatively associated with CBV knowledge, positive attitudes regarding CBV, a positive COVID-19 vaccine experience, anticipated regret of not having a CBV, white British ethnicity, and living in East Midlands (vs. London). Conclusions: Public health interventions promoting CBV may improve uptake through tailored messaging directed towards the specific decision stage relating to having a COVID-19 booster.

show abstract

Section: Beliefs and Attitudes About Covid-19 And Covid-19 Booster Va...mentioning

confidence: 99%

Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England

Meyer¹,

Goffe²,

Antonopoulou³

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…Up to 30% of adults endorse some fear of needles, and ~4% meet diagnostic criteria for blood–injection–injury phobia, which is characterized by an intense fear of blood, injections, and injury (Stinson et al, 2007 ; McLenon & Rogers, 2018 ). The literature documenting the relationship between heightened vaccine relevant fears and reduced vaccine intention or acceptance both prior to and during the COVID‐19 pandemic is robust (Freeman et al, 2021 ; Gusmano & Michel, 2009 ; Hamilton et al, 2021 ; Landowska et al, 2017 ; McLenon & Rogers, 2018 ; Newman et al, 2013 ; Taddio et al, 2012 ). A demographically representative survey of 15,014 adults within the United Kingdom found that higher scores on the blood and injection subscales of the Medical Fears Survey‐Short Form was associated with greater COVID‐19 vaccine hesitancy (Freeman et al, 2021 ).…”

Section: Introductionmentioning

confidence: 99%

“…Heightened fear is negatively associated with seasonal influenza vaccine uptake; however, most research has relied on cross‐sectional survey design (e.g., Hamilton et al, 2021 ; Landowska et al, 2017 ; Millner et al, 2010 ), and has focused on retrospective reports of vaccination behavior, or intention/anticipated likelihood of future vaccination behavior (Borthwick et al, 2021 ). It is rare that a longitudinal approach is taken to predict subsequent vaccine uptake behavior.…”

Section: Introductionmentioning

confidence: 99%

Predicting COVID‐19 and seasonal influenza vaccine uptake: The impact of fear and vasovagal symptoms

Kowalsky

2022

Applied Psych Health & Well

View full text Add to dashboard Cite

Vaccines are vital to protecting health. However, fear and experiencing vasovagal symptoms (e.g., dizziness) are deterrents to medical procedures. Thus, study aims were to test (1) if vaccine relevant fears predict vasovagal symptoms during or following seasonal influenza vaccination and (2) if vaccine relevant fears and vasovagal symptoms predict seasonal influenza and COVID‐19 vaccine uptake. Using a prospective design, 1077 participants recruited online completed surveys during Oct 2019 assessing vaccine relevant fears, and May–June 2020 assessing 2019–2020 seasonal influenza vaccine uptake, ratings of vasovagal symptoms, and seasonal influenza and COVID‐19 vaccination intention. A behavioral follow up assessing 2020–2021 seasonal influenza and COVID‐19 vaccine uptake took place June–July 2021. Heightened vaccine relevant fears predicted reduced 2019–2020 seasonal influenza vaccine uptake and greater vasovagal symptoms among those who did receive a seasonal influenza vaccine. Serial mediation analyses identified significant indirect effects with greater vaccine relevant fears reducing 2020–2021 seasonal influenza vaccine uptake through intention and reducing COVID‐19 vaccine uptake through vasovagal symptoms and intention. Intervention research to reduce fear and prevent vasovagal symptoms to support vaccine uptake is warranted.

show abstract

Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England

Meyer¹,

Goffe²,

Antonopoulou³

et al. 2023

Vaccine

View full text Add to dashboard Cite

Attitudes towards influenza and uptake of the flu vaccine: A survey of pharmacy staff working in English hospitals

Cited by 4 publications

References 24 publications

Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England

Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England

Predicting COVID‐19 and seasonal influenza vaccine uptake: The impact of fear and vasovagal symptoms

Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England

Contact Info

Product

Resources

About